Fig. 2.
Deterministic sensitivity analysis. AE adverse event, BTX botulinum toxin, EQ5D European Quality of Life questionnaire in five dimensions, ICER incremental cost-effectiveness ratio
Deterministic sensitivity analysis. AE adverse event, BTX botulinum toxin, EQ5D European Quality of Life questionnaire in five dimensions, ICER incremental cost-effectiveness ratio